An approach to the diagnosis and treatment of cryofibrinogenemia
Tshering Amdo, James Welker2004The American Journal of MedicineReview
Abstract
Cryofibrinogenemia is a rarely symptomatic disorder that is underrecognized due to the infrequency with which it causes symptoms. Although completely reversible, this disorder can be life threatening when untreated. In this review, the classification, pathophysiology, and clinical presentation of cryofibrinogenemia are described, based on case reports and prospective observational data. Diagnostic criteria are outlined, and therapies are assessed critically. This information should help clinicians in establishing a diagnosis of cryofibrinogenemia and initiating treatment.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Cited By (5)
- Clinical significance of cryofibrinogenemia: possible pathophysiological link with Raynaud’s phenomenonThe Journal of Rheumatology · 2011
- Cryofibrinogenemia: new insights into clinical and pathogenic featuresThe American Journal of Medicine · 2009
- Stanozolol treatment for successful prevention of attacks of severe primary cryofibrinogenemiaPediatric Blood & Cancer · 2010
- Outcome of essential cryofibrinogenaemia in a series of 61 patientsLara D. Veeken · 2007
- A 5-year prospective follow-up study in essential cryofibrinogenemia patientsAutoimmunity Reviews · 2011